Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)

Clinical trial NCT04768296 · COMPLETED

Trial details

NCT number: NCT04768296
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer

Start date: 2021-03-29
Primary completion: 2023-07-21
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.